|
HNRNPU expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.5516000140845E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56190000044631E-07 |
| Normal-vs-Stage2 |
3.54049999999884E-05 |
| Normal-vs-Stage3 |
7.94259999992164E-08 |
| Normal-vs-Stage4 |
2.22849999997887E-06 |
| Stage1-vs-Stage2 |
6.325000E-01 |
| Stage1-vs-Stage3 |
4.137400E-01 |
| Stage1-vs-Stage4 |
4.866200E-01 |
| Stage2-vs-Stage3 |
9.090800E-01 |
| Stage2-vs-Stage4 |
9.410800E-01 |
| Stage3-vs-Stage4 |
9.704000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.4499000019278E-09 |
| Normal-vs-AfricanAmerican |
1.466440E-01 |
| Normal-vs-Asian |
4.35420000000075E-05 |
| Caucasian-vs-AfricanAmerican |
2.427600E-02 |
| Caucasian-vs-Asian |
9.178800E-01 |
| AfricanAmerican-vs-Asian |
5.357800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77829999614687E-08 |
| Normal-vs-Female |
3.91229999507914E-08 |
| Male-vs-Female |
3.634200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.53999999999532E-06 |
| Normal-vs-Age(41-60Yrs) |
7.73760000516432E-09 |
| Normal-vs-Age(61-80Yrs) |
8.07810000003073E-07 |
| Normal-vs-Age(81-100Yrs) |
3.108100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.611000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.166000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.682600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.672000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.451000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.347800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.942400E-02 |
| Classical-VS-Follicular |
1.003440E-04 |
| Classical-VS-Other |
9.459600E-02 |
| Classical-VS-Normal |
2.27649999995361E-06 |
| Tall-VS-Follicular |
4.308200E-01 |
| Tall-VS-Other |
3.869000E-01 |
| Tall-VS-Normal |
4.12650000003456E-06 |
| Follicular-VS-Other |
7.466600E-01 |
| Follicular-VS-Normal |
2.59550003711695E-09 |
| Other-VS-Normal |
3.842400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49010004335537E-09 |
| Normal-vs-N1 |
2.10159999958215E-07 |
| N0-vs-N1 |
4.894200E-01 |
|
|
